V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 180000650 | 180000080 | null | null | null | null | 2018-10-10 | null | null | null | TRIAL UNSPECIFIED | 101731003 |
| 180000670 | 180000082 | null | null | null | null | 2019-02-12 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101531313 |
| 180000690 | 180000083 | null | null | null | null | 2019-01-23 | null | null | null | SORAFENIB | 100940003 |
| 180000694 | 180000084 | null | null | null | null | 2017-05-25 | null | null | null | PEMBROLIZUMAB | 100181750 |
| 180000701 | 180000086 | null | null | null | null | 2021-05-14 | null | null | null | CISPLATIN + RT | 101209688 |
| 180000747 | 180000091 | null | null | null | null | 2014-06-29 | null | null | null | CNS GCT II GERMINOMA - CARBO ETOP | 100445297 |
| 180000769 | 180000094 | null | null | Curative (C) | null | 2017-10-12 | null | null | null | MITOTANE | 101829709 |
| 180000806 | 180000098 | null | null | null | null | 2017-08-27 | null | null | null | NOT MATCHED | 100568746 |
| 180000810 | 180000099 | null | null | null | null | 2019-04-02 | null | null | null | CISPLATIN + DOXORUBICIN + ETOPOSIDE + MITOTANE | 101237459 |
| 180000814 | 180000100 | null | null | null | null | 2016-02-29 | null | null | null | LENVATINIB | 100615794 |
| 180000823 | 180000102 | null | null | null | null | 2020-05-06 | null | null | null | NB HRNBL-1 COJEC IND COURSE A | 100608083 |
| 180000899 | 180000108 | null | null | null | null | 2018-12-14 | null | null | null | MITOTANE | 100706765 |
| 180000904 | 180000110 | null | null | null | null | 2019-12-30 | null | null | null | MITOTANE | 100255511 |
| 180000910 | 180000112 | null | null | null | null | 2017-06-03 | null | null | null | SORAFENIB | 100967731 |
| 180000931 | 180000118 | null | null | null | null | 2020-05-29 | null | null | null | CNS GCT II GERMINOMA - CARBO ETOP | 101816204 |
| 180001023 | 180000125 | null | null | Palliative (P) | null | 2018-06-16 | null | null | null | STREPTOZOCIN | 100629763 |
| 180001027 | 180000127 | null | null | null | null | 2017-06-02 | null | null | null | LENVATINIB | 101539619 |
| 180001054 | 180000129 | null | null | null | null | 2016-11-20 | null | null | null | CISPLATIN + DOXORUBICIN + ETOPOSIDE + MITOTANE | 101317890 |
| 180001082 | 180000134 | null | null | null | null | 2017-08-17 | null | null | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101051713 |
| 180001085 | 180000136 | null | null | null | null | 2019-01-13 | null | null | null | CNS PNET | 100801856 |
| 180001100 | 180000138 | null | null | Palliative (P) | null | 2018-01-09 | null | null | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101382347 |
| 180001176 | 180000146 | null | null | null | null | 2019-02-23 | null | null | null | PACLITAXEL + TRASTUZUMAB | 101323400 |
| 180001239 | 180000152 | null | null | null | null | 2016-07-16 | null | null | null | CARBOPLATIN + ETOPOSIDE | 100591656 |
| 180001252 | 180000154 | null | null | null | null | 2017-05-20 | null | null | null | CARBOPLATIN | 100547778 |
| 180001286 | 180000160 | null | null | null | null | 2019-07-22 | null | null | null | NB LOW/INTERM RISK GUIDELINES CARBO/ETOP | 101689455 |
| 180001308 | 180000165 | null | null | null | null | 2019-03-13 | null | null | null | NB HRNBL-1 COJEC IND COURSE A | 101380198 |
| 180001357 | 180000169 | null | null | null | null | 2019-02-08 | null | null | null | LENVATINIB | 100427761 |
| 180001366 | 180000171 | null | null | null | null | 2020-03-22 | null | null | null | WT SIOP 2002 01 PRE OP VADV | 100522485 |
| 180001368 | 180000172 | null | null | 03 | null | 2017-06-09 | null | null | null | TEMOZOLOMIDE | 101451313 |
| 180001377 | 180000173 | null | null | Palliative (P) | null | 2018-01-31 | null | null | null | CABOZANTINIB | 100039177 |
| 180001382 | 180000175 | null | null | Palliative (P) | null | 2018-03-17 | null | null | null | TRIAL | 100480694 |
| 180001453 | 180000180 | null | null | null | null | 2018-09-15 | null | null | null | TRASTUZUMAB | 100251538 |
| 180001462 | 180000182 | null | null | null | null | 2019-06-08 | null | null | null | CNS PNET | 100311567 |
| 180001572 | 180000199 | null | null | null | null | 2020-09-15 | null | null | null | NOT MATCHED | 101519774 |
| 180001575 | 180000200 | null | null | null | null | 2018-04-27 | null | null | null | MITOTANE | 100131600 |
| 180001626 | 180000204 | null | null | null | null | 2016-05-03 | null | null | null | ABVD | 100413368 |
| 180001716 | 180000219 | null | null | null | null | 2019-10-14 | null | null | null | CISPLATIN + DOXORUBICIN + ETOPOSIDE + MITOTANE | 101399488 |
| 180001748 | 180000221 | null | null | Curative (C) | null | 2018-11-14 | null | null | null | CABOZANTINIB | 100977464 |
| 180001757 | 180000224 | null | null | null | null | 2016-10-29 | null | null | null | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | 100919378 |
| 180001763 | 180000225 | null | null | Neo-adjuvant (N) | null | 2016-05-11 | null | null | null | CABOZANTINIB | 100237539 |
| 180001777 | 180000228 | null | null | null | null | 2020-02-14 | null | null | null | TRIAL | 100508713 |
| 180001796 | 180000232 | null | null | null | null | 2021-12-17 | null | null | null | MITOTANE | 100918136 |
| 180001815 | 180000234 | null | null | null | null | 2020-05-16 | null | null | null | CISPLATIN + DOXORUBICIN + ETOPOSIDE + MITOTANE | 101863739 |
| 180001829 | 180000237 | null | null | null | null | 2018-10-30 | null | null | null | DOCETAXEL | 100526364 |
| 180001830 | 180000238 | null | null | Palliative (P) | null | 2021-07-12 | null | null | null | NB HRNBL-1 COJEC IND COURSE A | 101632960 |
| 180001845 | 180000240 | null | null | null | null | 2020-02-21 | null | null | null | CARBOPLATIN + PACLITAXEL | 100745492 |
| 180001846 | 180000241 | null | null | null | null | 2019-01-06 | null | null | null | CISPLATIN | 101076881 |
| 180001851 | 180000242 | null | null | null | null | 2019-04-14 | null | null | null | NB HRNBL-1 COJEC IND COURSE A | 101762649 |
| 180001855 | 180000243 | null | null | null | null | 2019-12-03 | null | null | null | NB LOW/INTERM RISK GUIDELINES CARBO/ETOP | 100849373 |
| 180001878 | 180000246 | null | null | null | null | 2019-11-28 | null | null | null | BEVACIZUMAB + CARBO + PACLITAXEL | 101113763 |